Format

Send to

Choose Destination
J Pharm Pharm Sci. 2012;15(5):669-79.

Applications of β-limit dextrin as a matrix forming excipient for fast disintegrating buccal dosage formats.

Author information

1
Glycologic Limited, 70 Cowcaddens Road, Glasgow, UK. e.qi@glycologic.co.uk

Abstract

PURPOSE:

To compare the properties of buccal delivery matrices (wafers) made with dextrin, β-limit dextrin and pre-gelatinised starch.

METHODS:

The constituent α-glucans were tested for their mucoadhesive properties in solution plus their content of crystalline material (differential scanning calorimetry, DSC). Wafers were made by lyophilisation of aqueous solutions/dispersions of the α-glucans. Physical properties of the wafers were evaluated using texture analysis, dissolution coupled to photography and scanning electron microscopy (SEM).

RESULTS:

The results highlighted how the β-limit dextrins chemical and physical properties were ideally suited for the production of buccal delivery wafers. Dissolution testing confirmed the excellent hydration profile of the β-limit dextrin (within wafers) with time. Using SEM it was evident that the homogeneous "bee-hive" like structure of the β-limit dextrin wafers, unlike the other α-glucans, provided a rapidly hydratable strong porous matrix.

CONCLUSIONS:

The β-limit dextrin α-glucan makes a superb (lyophilised) mucoadhesive delivery structure for the delivery of active agents to the buccal mucosa.

PMID:
23331905
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Canadian Society for Pharmaceutical Sciences
Loading ...
Support Center